PortfoliosLab logoPortfoliosLab logo
PANW vs. NVO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PANW vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Palo Alto Networks, Inc. (PANW) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PANW achieves a 51.80% return, which is significantly higher than NVO's -10.74% return. Over the past 10 years, PANW has outperformed NVO with an annualized return of 29.12%, while NVO has yielded a comparatively lower 7.56% annualized return.


PANW

1D
0.03%
1M
22.75%
YTD
51.80%
6M
45.87%
1Y
41.46%
3Y*
33.77%
5Y*
35.61%
10Y*
29.12%

NVO

1D
-0.18%
1M
-6.80%
YTD
-10.74%
6M
-9.50%
1Y
-43.34%
3Y*
-15.59%
5Y*
2.92%
10Y*
7.56%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PANW vs. NVO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PANW
Palo Alto Networks, Inc.
51.80%1.23%23.41%111.32%-24.81%56.66%53.68%22.78%29.95%15.91%
NVO
Novo Nordisk A/S
-10.74%-39.22%-15.93%54.84%22.66%63.52%23.33%28.70%-12.98%52.92%

Correlation

The correlation between PANW and NVO is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.23

Correlation (3Y)
Calculated over the trailing 3-year period

0.23

Correlation (5Y)
Calculated over the trailing 5-year period

0.24

Correlation (10Y)
Calculated over the trailing 10-year period

0.23

Correlation (All Time)
Calculated using the full available price history since Jul 20, 2012

0.24

Fundamentals

Market Cap

PANW:

$208.04B

NVO:

$195.21B

EPS

PANW:

$1.17

NVO:

DKK 27.42

PE Ratio

PANW:

238.46

NVO:

10.34

PEG Ratio

PANW:

0.02

NVO:

0.44

PS Ratio

PANW:

18.95

NVO:

3.85

PB Ratio

PANW:

7.52

NVO:

6.21

Total Revenue (TTM)

PANW:

$10.61B

NVO:

DKK 327.80B

Gross Profit (TTM)

PANW:

$7.63B

NVO:

DKK 268.30B

EBITDA (TTM)

PANW:

$1.33B

NVO:

DKK 181.54B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PANW vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PANW
PANW Risk / Return Rank: 6969
Overall Rank
PANW Sharpe Ratio Rank: 7575
Sharpe Ratio Rank
PANW Sortino Ratio Rank: 6969
Sortino Ratio Rank
PANW Omega Ratio Rank: 7070
Omega Ratio Rank
PANW Calmar Ratio Rank: 6666
Calmar Ratio Rank
PANW Martin Ratio Rank: 6666
Martin Ratio Rank

NVO
NVO Risk / Return Rank: 1212
Overall Rank
NVO Sharpe Ratio Rank: 99
Sharpe Ratio Rank
NVO Sortino Ratio Rank: 1212
Sortino Ratio Rank
NVO Omega Ratio Rank: 1010
Omega Ratio Rank
NVO Calmar Ratio Rank: 1212
Calmar Ratio Rank
NVO Martin Ratio Rank: 1616
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PANW vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Palo Alto Networks, Inc. (PANW) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PANWNVODifference
Sharpe ratioReturn per unit of total volatility

+1.91

Sortino ratioReturn per unit of downside risk

+2.61

Omega ratioGain probability vs. loss probability

1.21

0.85

+0.35

Calmar ratioReturn relative to maximum drawdown

1.16

-0.80

+1.96

Martin ratioReturn relative to average drawdown

2.62

-1.18

+3.80

PANW vs. NVO - Sharpe Ratio Comparison

The current PANW Sharpe Ratio is 1.07, which is higher than the NVO Sharpe Ratio of -0.84. The chart below compares the historical Sharpe Ratios of PANW and NVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

PANW vs. NVO - Drawdown Comparison

The maximum PANW drawdown since its inception was -47.98%, smaller than the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for PANW and NVO.


Loading charts...

Drawdown Indicators


PANWNVODifference

Max Drawdown

Largest peak-to-trough decline

-47.98%

-74.70%

+26.72%

Max Drawdown (1Y)

Largest decline over 1 year

-36.01%

-54.34%

+18.33%

Max Drawdown (3Y)

Largest decline over 3 years

-36.01%

-74.70%

+38.69%

Max Drawdown (5Y)

Largest decline over 5 years

-36.01%

-74.70%

+38.69%

Max Drawdown (10Y)

Largest decline over 10 years

-47.98%

-74.70%

+26.72%

Current Drawdown

Current decline from peak

-6.94%

-68.11%

+61.17%

Average Drawdown

Average peak-to-trough decline

-14.68%

-17.79%

+3.11%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.87%

37.62%

-21.75%

Volatility

PANW vs. NVO - Volatility Comparison

Palo Alto Networks, Inc. (PANW) has a higher volatility of 16.97% compared to Novo Nordisk A/S (NVO) at 10.68%. This indicates that PANW's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PANWNVODifference

Volatility (1M)

Calculated over the trailing 1-month period

16.97%

10.68%

+6.29%

Volatility (6M)

Calculated over the trailing 6-month period

32.33%

38.04%

-5.71%

Volatility (1Y)

Calculated over the trailing 1-year period

38.96%

51.88%

-12.92%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

41.72%

38.33%

+3.39%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

38.62%

32.56%

+6.06%

Dividends

PANW vs. NVO - Dividend Comparison

PANW has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 4.11%.


PositionTTM20252024202320222021202020192018201720162015
NVO
Novo Nordisk A/S
4.11%3.31%1.68%1.00%1.20%1.35%1.87%2.14%1.45%1.52%2.87%0.92%
PANW
Palo Alto Networks, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

PANW vs. NVO - Financials Comparison

This section allows you to compare key financial metrics between Palo Alto Networks, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B100.00B20222023202420252026
3.00B
96.82B
(PANW) Total Revenue
(NVO) Total Revenue
Please note, different currencies. PANW values in USD, NVO values in DKK

PANW vs. NVO - Profitability Comparison

The chart below illustrates the profitability comparison between Palo Alto Networks, Inc. and Novo Nordisk A/S over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

70.0%75.0%80.0%85.0%20222023202420252026
67.6%
86.0%
Portfolio components
PANW - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Palo Alto Networks, Inc. reported a gross profit of 2.03B and revenue of 3.00B. Therefore, the gross margin over that period was 67.6%.

NVO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.

PANW - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Palo Alto Networks, Inc. reported an operating income of -186.00M and revenue of 3.00B, resulting in an operating margin of -6.2%.

NVO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.

PANW - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Palo Alto Networks, Inc. reported a net income of -177.00M and revenue of 3.00B, resulting in a net margin of -5.9%.

NVO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.


Frequently Asked Questions


PANW and NVO have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PANW has higher volatility (16.97%) compared to NVO (10.68%). In terms of maximum drawdown, PANW dropped -47.98% vs NVO's -74.70%.

PANW currently has the higher Sharpe Ratio (1.07 vs -0.84), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PANW and NVO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer